Acquisitions (Tables)

The following are the identifiable intangible assets acquired and their respective fair value and estimated useful lives (dollars in millions):



Total consideration transferred:
Cash paid, net of cash acquired	$	8.8
Fair value of contingent consideration	9.9
Net purchase price	$	18.7
Fair value of assets acquired and liabilities assumed:
Accounts receivable	$	0.4
Definite-lived intangible assets	6.2
Goodwill	13.4
Total assets acquired	20.0
Current liabilities	0.1
Deferred tax liabilities	1.2
Total liabilities assumed	1.3
Fair value of net assets acquired:	$	18.7



	Amount		Estimated Useful Life (Years)
Customer relationships	$	56.3	10
Backlog	4.7		1
Trade name	1.4		5
Total	$	62.4



Total consideration transferred:
Cash paid, net of cash acquired	$	93.6
Fair value of assets acquired and liabilities assumed:
Accounts receivable	$	4.9
Other Current Assets	1.3
Property and equipment, net	2.0
Definite-lived intangible assets	62.4
Goodwill	24.1
Total assets acquired	94.7
Current liabilities	1.1
Total liabilities assumed	1.1
Fair value of net assets acquired:	$	93.6

The following are the identifiable intangible assets acquired and their respective estimated useful lives, as determined based on valuations (dollars in millions):



	Amount		Estimated Useful Life (Years)
Customer relationships	$	11.6	10
Technology	1.8		3
Trade name	1.6		5
Total	$	15.0

The components of the consideration transferred in conjunction with the Health Advances acquisition and the fair value allocation of that consideration is as follows (dollars in millions):



Total consideration transferred:
Cash paid, net of cash acquired	$	67.3
Receivable from working capital adjustment	(0.2		)
Fair value of contingent consideration	4.5
Net purchase price	$	71.6
Allocation of consideration transferred:
Accounts receivable	$	4.0
Other current assets	0.7
Property and equipment, net	1.0
Deferred tax assets	0.2
Definite-lived intangible assets	15.0
Goodwill	52.5
Total assets acquired	73.4
Current liabilities	1.8
Total liabilities assumed	1.8
Net assets acquired:	$	71.6

The following are the identifiable intangible assets acquired and their respective estimated useful lives, based on valuations (dollars in millions):

The components of the consideration transferred in conjunction with the ExecuPharm acquisition and the allocation of that consideration is as follows (in millions):



Total consideration transferred:
Cash paid, net of cash acquired	$	148.5
Fair value of contingent consideration	9.4
Deferred payment	9.3
Net purchase price	$	167.2
Allocation of consideration transferred:
Accounts receivable	$	29.2
Other current assets	0.1
Property and equipment, net	0.9
Definite-lived intangible assets	87.1
Goodwill	58.6
Total assets acquired	175.9
Current liabilities	8.7
Total liabilities assumed	8.7
Net assets acquired:	$	167.2

The following are the identifiable intangible assets acquired and their respective estimated useful lives, based on valuations (dollars in millions):



	Amount		Estimated Useful Life (Years)
Customer relationships	$	7.5	10
Trade name	0.7		3
Backlog	2.0		1
Total	$	10.2

The components of the consideration transferred in conjunction with the TMAC acquisition and the allocation of that consideration are as follows (in millions):



Total consideration transferred:
Cash paid, net of cash acquired	$	36.3
Fair value of contingent consideration	2.1
Net purchase price	$	38.4
Allocation of consideration transferred:
Accounts receivable	$	4.7
Other current assets	0.1
Property and equipment, net	0.3
Definite-lived intangible assets	10.2
Goodwill	25.8
Total assets acquired	41.1
Current liabilities	2.7
Total liabilities assumed	2.7
Net assets acquired:	$	38.4

Estimated Useful Life (Years)

Customer relationships

Technology